SION — SIONNA THERAPEUTICS INC
As of Q2 2026, 28 SEC-registered investment managers reported holding SION (SIONNA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $463.80M across 11.05M shares. That is +31.7% by share count (+2.66M shares) versus the previous quarter, while reported value moved +51.4%. Ownership is concentrated: the five largest holders account for 73.4% of reported value and the top ten for 89.4%.
Compared with the prior quarter, 4 opened new positions, 16 added to existing stakes, 7 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
SION is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Viking Global Investors history | Q2 2026 | 3.20M | $140.56M | 0.41% | Hold |
| BlackRock Inc history | Q2 2026 | 1.47M | $64.88M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 1.49M | $64.09M | 0.01% | New |
| Citadel Advisors history | Q2 2026 | 1.16M | $50.85M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 1.18M | $48.75M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 457.14K | $20.11M | 0.00% | Add |
| Casdin Capital history | Q2 2026 | 400.00K | $17.60M | 0.88% | New |
| Goldman Sachs Group history | Q2 2026 | 388.81K | $17.10M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 325.33K | $14.31M | 0.01% | Add |
| Franklin Resources history | Q2 2026 | 290.11K | $12.76M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 278.29K | $12.24M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 154.48K | $6.80M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 151.05K | $6.64M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 129.75K | $5.71M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 116.21K | $5.11M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 110.16K | $4.85M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 101.64K | $4.47M | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 88.91K | $3.91M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 53.35K | $2.35M | 0.00% | Add |
| Prudential Financial history | Q2 2025 | 135.19K | $2.35M | 0.00% | Add |
New Positions (Q2 2026)
- JPMorgan Chase & Co 1.49M sh · $64.09M
- Casdin Capital 400.00K sh · $17.60M
- D. E. Shaw & Co 101.64K sh · $4.47M
- Marshall Wace 12.60K sh · $554.23K
Fully Exited (vs previous quarter)
- Polen Capital Management sold 26.77K sh · $1.07M
- Two Sigma Investments sold 5.50K sh · $220.50K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|
| Viking Global Investors | 2.95M | 3.20M | 3.20M | 3.20M | 3.20M | 3.20M |
| BlackRock Inc | 198.40K | 637.10K | 844.61K | 1.29M | 1.30M | 1.47M |
| JPMorgan Chase & Co | 2.17M | 2.22M | 1.98M | 1.23M | — | 1.49M |
| Citadel Advisors | 326.50K | 129.91K | 35.92K | 1.09M | 1.17M | 1.16M |
| Geode Capital Management | 135.56K | 289.27K | 316.56K | 380.04K | 389.87K | 457.14K |
| Casdin Capital | — | — | — | — | — | 400.00K |
| Goldman Sachs Group | 63.74K | 46.05K | 12.18K | 36.27K | 263.17K | 388.81K |
| Millennium Management | 179.07K | 14.03K | 214.09K | 80.55K | 140.64K | 325.33K |
| Franklin Resources | 500.02K | 500.02K | 242.15K | 175.48K | 175.48K | 290.11K |
| Fidelity Management & Research (FMR) | — | — | 234 | 384 | 81.39K | 278.29K |
| Northern Trust Corp | 26.82K | 91.89K | 97.71K | 112.12K | 116.78K | 154.48K |
| Morgan Stanley | 3.94K | 44.02K | 22.84K | 49.88K | 133.02K | 151.05K |
| Charles Schwab Investment Management | 64.64K | 92.83K | 111.50K | 123.69K | 120.25K | 129.75K |
| UBS Group AG | 11.15K | 51.37K | 46.67K | 89.18K | 147.64K | 116.21K |
| Citigroup Inc | — | 4.38K | 687 | 5.18K | 18.06K | 110.16K |
| D. E. Shaw & Co | — | — | — | 5.74K | — | 101.64K |
| Bank of America Corp | 8.74K | 6.01K | 6.54K | 43.57K | 50.87K | 88.91K |
| Deutsche Bank AG | — | 9.60K | 9.60K | 10.03K | 13.25K | 53.35K |
| Point72 Asset Management | — | — | — | — | 136.55K | 49.33K |
| BNY Mellon | — | 24.13K | 27.46K | 35.13K | 33.78K | 41.59K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details